Geographic Atrophy Clinical Trials

120 clinical trials for Geographic Atrophy across international registries, including 24 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251 — RECRUITING · PHASE2
• A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy — RECRUITING · PHASE3
• Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration — RECRUITING · PHASE1
• Phase 1 Study of C.001 in Retinal Degeneration — RECRUITING · PHASE1
• A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy — RECRUITING
• Adaptive Optics Scanning Light Ophthalmoscopy (AOSLO) and Microperimetry (MP) Sub-study — RECRUITING · NA
• Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants — RECRUITING · PHASE1
• Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD — RECRUITING · PHASE2
• Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration — RECRUITING · PHASE1
• A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) — RECRUITING · PHASE2
• A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration — RECRUITING · PHASE1
• High Resolution Retinal Imaging — RECRUITING
• Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study — RECRUITING
• Real-time Acoustic Biofeedback for Enhancing Fixation Stability: A Proof-of-concept Study to Improve Ophthalmic Imaging Diagnostic Quality — RECRUITING · NA
• A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy) — RECRUITING · PHASE2
• A RANDOMIZED, DOUBLE MASKED, PLACEBO-CONTROLLED, MULTICENTER, DOSE-RANGE FINDING STUDY TO ASSESS THE EFFICACY AND SAFETY OF FWY003 IN PARTICIPANTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION. — RECRUITING
• SGLT2 Inhibitors in Geographic Atrophy — RECRUITING · PHASE2
• Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration — RECRUITING · PHASE1
• A PHASE 2 MULTICENTER, RANDOMIZED, DOUBLE-MASKED, SHAM CONTROLLED, REFERENCE-ARM STUDY TO EVALUATE EFFICACY AND SAFETY OF ONL1204 IN PATIENTS WITH GEOGRAPHIC ATROPHY (GA) ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION (AMD) — RECRUITING · PHASE2
• Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression — RECRUITING
• A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT — RECRUITING
• Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD — RECRUITING · NA
• Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. — RECRUITING · PHASE1
• Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression — RECRUITING
• A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration — ACTIVE_NOT_RECRUITING · PHASE4
• A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) — TERMINATED · PHASE1
• Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy — ACTIVE_NOT_RECRUITING · PHASE1
• Safety and Efficacy Study of Novel Gene Therapy AGX-08 for Geographic Atrophy — NOT_YET_RECRUITING · PHASE1
• Retinal Fundus Flavoprotein Fluorescence in Age Related Macular Degeneration — COMPLETED · NA
• A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy — ACTIVE_NOT_RECRUITING · PHASE2
• Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy — COMPLETED · PHASE1
• Long-term Extension Study for Participants with Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 Parent Clinical Studies — TERMINATED · PHASE2
• An Open-label Safety, Tolerability and Exploratory Efficacy Clinical Trial of PST-611 in Geographic Atrophy — NOT_YET_RECRUITING · PHASE2
• COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy — COMPLETED · NA
• Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD — ACTIVE_NOT_RECRUITING · NA
• A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration — ACTIVE_NOT_RECRUITING
• A Study in Adults With Geographic Atrophy — NOT_YET_RECRUITING · PHASE2
• A Study of the SING IMT in an Israeli Cohort — WITHDRAWN · NA
• Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy — COMPLETED · PHASE3
• A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy — ACTIVE_NOT_RECRUITING · PHASE2
• Evaluating the Relationship Between Function and Structure Using Data From a GA Natural History Cohort — COMPLETED
• Pterygopalatine Ganglion Stimulation for the Treatment of Geographic Atrophy — NOT_YET_RECRUITING · NA
• A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA) — ACTIVE_NOT_RECRUITING · PHASE3
• Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants — TERMINATED · PHASE1
• A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) — COMPLETED · PHASE2
• Validation of Virtual Reality Tests for the Assessment of Patients With Age-related Macular Degeneration as Clinical Endpoints — NOT_YET_RECRUITING · NA
• Subtenon PRP Injection for Geographic Atrophy in Dry Age-Related Macular Degeneration — COMPLETED · NA
• FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD — TERMINATED · PHASE1
• PHase 3, Multicenter, RandOmized, Double-masked, PlacEbo-CoNtrolled Study of TInlarebant to EXplore Safety and Efficacy in the Treatment of Geographic Atrophy (the PHOENIX Study) — TERMINATED · PHASE3
• Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy — ACTIVE_NOT_RECRUITING · PHASE3

Refine this search